November 21, 2025 a 03:43 pm
KVUE: Fundamental Ratio Analysis - Kenvue Inc.
Kenvue Inc. is a notable player in the consumer health sector with a diversified product range. The company's operations under trusted brands such as Tylenol, Neutrogena, and Listerine provide a solid foundation for stable revenue streams. While being a subsidiary of Johnson & Johnson offers brand strength, investors should weigh market competition and operational challenges within the global landscape.
Fundamentals Rating
Based on the latest metrics, Kenvue exhibits solid performance in profitability with room for improvement in financial health ratios.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 4 | |
| Return On Assets | 4 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 2 |
Historical Rating
The historical data shows consistent performance metrics with slight variations over time, maintaining a stable overall score.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-11-21 | 3 | 4 | 4 | 4 | 1 | 2 | 2 |
| Previous | 0 | 4 | 4 | 4 | 1 | 2 | 2 |
Analyst Price Targets
Analyst estimates suggest a balanced outlook with moderate growth potential, reflecting consensus on value stability.
| High | Low | Median | Consensus |
|---|---|---|---|
| $23 | $15 | $18 | $18.57 |
Analyst Sentiment
The current analyst sentiment is leaning towards a 'Hold' recommendation, with a majority favoring neither buying nor selling shares at present market conditions.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 5 | |
| Hold | 9 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Kenvue Inc. presents a solid investment opportunity with robust fundamentals, bolstered by established brand recognition under Johnson & Johnson's umbrella. Despite this, the conservative outlook reflected in analyst ratings signals caution amid market volatility. Investors need to consider competitive pressures within the consumer health sector. A long-term view may benefit from Kenvue's innovation and strategic positioning in essential health markets.